13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001545692
Total reported value
$328.2M
$328.2M
8 檔
49.9%
During the Q3 2024 filing period, NVP Associates, LLC (CIK: 0001545692) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $328.2M across 8 reported positions.
In Q3 2024, NVP Associates, LLC displayed an active expansion posture, initiating 2 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MBX | Mbx Biosciences Inc | Stock-Other | 31.51% | -0.27% | — | |
| 2 | ZBIO | Zenas Biopharma Inc | Stock-Other | 17.66% | -6.18% | — | |
| 3 | TALK | Talkspace Inc | Stock-Other | 17.45% | — | — | |
| 4 | DAVE | Dave Inc | Stock-Other | 13.22% | — | — | |
| 5 | 7WH | Udemy Inc | Stock-Other | 13.16% | — | — | |
| 6 | OPEN | Opendoor Technologies Inc | Stock-Real Estate | 4.76% | — | — | |
| 7 | GROV | Grove Collaborative Holdings | Stock-Other | 2.26% | -1.11% | — | |
| 8 | ✓ | Digital Brands Group Inc | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MBX | Mbx Biosciences Inc | +31.5% | NEW | New buy |
| 2 | ZBIO | Zenas Biopharma Inc | +17.7% | NEW | New buy |
| 3 | ✓ | Digital Brands Group Inc | — | — | Unchanged |
| 4 | GROV | Grove Collaborative Holdings | -3.5% | — | Unchanged |
| 5 | OPEN | Opendoor Technologies Inc | -3.7% | — | Unchanged |
| 6 | DAVE | Dave Inc | -6.1% | — | Unchanged |
| 7 | 7WH | Udemy Inc | -16.3% | — | Unchanged |
| 8 | TALK | Talkspace Inc | -19.6% | — | Unchanged |
According to official SEC Form 13F filings, NVP Associates, LLC reported a total U.S. public equity portfolio value of $328.2M across 8 disclosed positions in Q3 2024.
During Q3 2024, NVP Associates, LLC's top holdings by market value included MBX (31.5%)、ZBIO (17.7%)、TALK (17.4%). The largest single position, MBX, represented 31.5% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including MBX, ZBIO, TALK) accounted for 49.9% of total reported equity market value during Q3 2024.
Top New Position Initiated
MBX
市值: $55.5M
In Q3 2024, NVP Associates, LLC made 2 total portfolio adjustments, initiating 2 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.